+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations

Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations

Annals of Oncology 27(4): 738-744

Whole-genome sequencing studies have recently shown that osteosarcomas (OSs) display high rates of structural variation, i.e. they contain many somatic mutations and copy number alterations. TP53 and RB1 show recurrent somatic alterations in concordant studies, suggesting that they could be key players in bone oncogenesis. we carried out whole-genome sequencing of DNA from seven high-grade OS samples matched with normal tissue from the same patients. We confirmed the presence of genetic alterations of the TP53 (including novel unreported mutations) and RB1 genes. Most interestingly, we identified a total of 84 point mutations and 4 deletions related to 82 different genes in OS samples, of which only 15 have been previously reported. Interestingly, the number of mutated genes (ranging from 4 to 8) was lower in TP53mut cases compared with TP53wt cases (ranging from 14 to 45). This was also true for the mutated RB1 case. We also observed that a dedifferentiated OS harboring MDM2 amplification did not carry any other mutations. This study suggests that bone oncogenesis driven by TP53 or RB1 mutations occurs on a background of relative genetic stability and that the dedifferentiated OS subtype represents a clinico-pathological entity with distinct oncogenic mechanisms and thus requires different therapeutic management.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 059270051

Download citation: RISBibTeXText

PMID: 26787232

DOI: 10.1093/annonc/mdw009

Related references

Whole Exome Sequencing Reveals a Large Genetic Heterogeneity and Revisits the Causes of Hypertrophic Cardiomyopathy. Circulation. Genomic and Precision Medicine 12(5): E002500, 2019

Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity. Bmc Medical Genetics 14: 118, 2013

Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer. International Journal of Cancer 142(5): 927-939, 2018

Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Research 75(2): 264-269, 2015

Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis. Plos one 8(1): E53310, 2013

Whole exome sequencing in 342 congenital cardiac left sided lesion cases reveals extensive genetic heterogeneity and complex inheritance patterns. Genome Medicine 9(1): 95, 2017

Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases. Cancer Research 79(1): 7, 2019

Whole exome sequencing reveals novel somatic alterations in neuroblastoma patients with chemotherapy. Cancer Cell International 18: 21, 2018

Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines. Plos one 6(6): E21097, 2011

Whole-exome sequencing reveals ZNF408 as a new gene associated with autosomal recessive retinitis pigmentosa with vitreal alterations. Human Molecular Genetics 24(14): 4037-4048, 2015

Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma. Clinical Cancer Research 24(4): 939-949, 2018

Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity. Cell Reports 25(6): 1446-1457, 2018

Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech. Journal of Neurodevelopmental Disorders 5(1): 29, 2013

Targeted exome sequencing profiles genetic alterations in leiomyosarcoma. Genes Chromosomes and Cancer 55(2): 124-130, 2016

First applications of a targeted exome sequencing approach in fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects. Peerj 4: E1955, 2016